Invariant natural killer T cells in lung diseases

참고문헌 (159)

1. Godfrey, D. I., "NKT cells : what’s in a name? Nat", Rev. Immunol, 4, pp.231~237 (2004)
2. Burdin, N., "Selective ability of mouse CD1 to present glycolipids : alphagalactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes", J. Immunol, 161, pp.3271~3281 (1998)
3. Oh, S. J., "Role of type II NKT cells in the suppression of graft-versus-host disease", Crit. Rev. Immunol, 28, pp.249~267 (2008)
4. Houston, S., "iNKT cells circulate", Nat. Immunol, 23, pp.1653~ (2022)
5. Crosby, C. M., "Tissue-specific functions of invariant natural killer T cells", Nat. Rev. Immunol, 18, pp.559~574 (2018)
6. Lee, Y. J., "Tissue-specific distribution of iNKT cells impacts their cytokine response", Immunity, 43, pp.566~578 (2015)
7. Lynch, L., "Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production", Immunity, 37, pp.574~587 (2012)
8. Huang, W., "The role of CD1d and MR1 restricted T cells in the liver", Front. Immunol, 9, pp.2424~ (2018)
9. Lynch, L., "Adipose invariant natural killer T cells", Immunology, 142, pp.337~346 (2014)
10. Montoya, C. J., "Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11", Immunology, 122, pp.1~14 (2007)
11. Ahn, S., "GM-CSF and IL-4 produced by NKT cells inversely regulate IL-1beta production by macrophages", Immunol. Lett, 182, pp.50~56 (2017)
12. Kim, H. Y., "NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production", J. Exp. Med, 201, pp.41~47 (2005)
13. Woo, Y. D., "The invariant natural killer T cell-mediated chemokine X-C motif chemokine ligand 1-X-C motif chemokine receptor 1 axis promotes allergic airway hyperresponsiveness by recruiting CD103(+) dendritic cells", J. Allergy Clin. Immunol, 142, pp.1781~1792 (2018)
14. Terabe, M., "Tissue-specific roles of NKT cells in tumor immunity", Front. Immunol, 9, pp.1838~ (2018)
15. Zingaropoli, M. A., "Major reduction of NKT cells in patients with severe COVID-19 pneumonia", Clin. Immunol, 222, pp.108630~ (2021)
16. Dashtsoodol, N., "Identification of CD4(-)CD8(-)double-negative natural killer T cell precursors in the thymus", PLoS ONE, 3, pp.e3688~ (2008)
17. Bendelac, A., "Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes", J. Exp. Med, 182, pp.2091~2096 (1995)
18. Lazarevic, V., "The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells", Nat. Immunol, 10, pp.306~313 (2009)
19. Hogquist, K., "Recent advances in iNKT cell development", F1000Res, 9, pp.F1000~ (2020)
20. Kim, E. Y., "The transcriptional programs of iNKT cells", Semin. Immunol, 27, pp.26~32 (2015)
21. Wingender, G., "NKT10 cells : a novel iNKT cell subset", Oncotarget, 6, pp.26552~26553 (2015)
22. Cohen, N. R., "Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells", Nat. Immunol, 14, pp.90~99 (2013)
23. Georgiev, H., "Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets", Nat. Commun, 7, pp.13116~ (2016)
24. Lee, Y. J., "Lineage-specific effector signatures of invariant NKT cells are shared amongst gammadelta T, innate lymphoid, and Th cells", J. Immunol, 197, pp.1460~1470 (2016)
25. Lee, Y. J., "Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells", Nat. Immunol, 14, pp.1146~1154 (2013)
26. Lynch, L., "Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg)cells and macrophages in adipose tissue", Nat. Immunol, 16, pp.85~95 (2015)
27. Sag, D., "IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset", J. Clin. Invest, 124, pp.3725~3740 (2014)
28. Baranek, T., "Deconstructing iNKT cell development at single-cell resolution", Trends Immunol, 43, pp.503~512 (2022)
29. Engel, I., "Innate-like functions of natural killer T cell subsets result from highly divergent gene programs", Nat. Immunol, 17, pp.728~739 (2016)
30. Baranek, T., "High dimensional single-cell analysis reveals iNKT cell developmental trajectories and effector fate decision", Cell Rep, 32, pp.108116~ (2020)
31. Godfrey, D. I., "Control points in NKT-cell development", Nat. Rev. Immunol, 7, pp.505~518 (2007)
32. Borowski, C., "Signaling for NKT cell development : the SAP-FynT connection", J. Exp. Med, 201, pp.833~836 (2005)
33. Northrup, D., "Histone demethylases UTX and JMJD3 are required for NKT cell development in mice", Cell Biosci, 7, pp.25~ (2017)
34. Salio, M., "Essential role for autophagy during invariant NKT cell development", Proc. Natl Acad. Sci. USA, 111, pp.E5678~E5687 (2014)
35. Henao-Mejia, J., "The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis", Immunity, 38, pp.984~997 (2013)
36. Mao, A. P., "Multiple layers of transcriptional regulation by PLZF in NKT-cell development", Proc. Natl Acad. Sci. USA, 113, pp.7602~7607 (2016)
37. Moran, A. E., "T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse", J. Exp. Med, 208, pp.1279~1289 (2011)
38. Malhotra, N., "SOX4 controls invariant NKT cell differentiation by tuning TCR signaling", J. Exp. Med, 215, pp.2887~2900 (2018)
39. Cui, Y., "Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation", J. Clin. Invest, 125, pp.4171~4185 (2015)
40. Thomas, S. Y., "PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions", J. Exp. Med, 208, pp.1179~1188 (2011)
41. Johnston, B., "Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets", J. Immunol, 171, pp.2960~2969 (2003)
42. Scanlon, S. T., "Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation", J. Exp. Med, 208, pp.2113~2124 (2011)
43. Murray, M. P., "Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure", Nat. Commun, 12, pp.1446~ (2021)
44. Salou, M., "A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets", J. Exp. Med, 216, pp.133~151 (2019)
45. Hayward, S. L., "Environmental cues regulate epigenetic reprogramming of airway-resident memory CD8(+)T cells", Nat. Immunol, 21, pp.309~320 (2020)
46. Lavin, Y., "Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment", Cell, 159, pp.1312~1326 (2014)
47. Meyer, E. H., "iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity", J. Immunol, 179, pp.4661~4671 (2007)
48. Thomas, S. Y., "CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells", J. Immunol, 171, pp.2571~2580 (2003)
49. Semmling, V., "Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs", Nat. Immunol, 11, pp.313~320 (2010)
50. Gonzalo, J. A., "Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation", J. Immunol, 163, pp.403~411 (1999)
51. Kawasaki, S., "Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice", J. Immunol, 166, pp.2055~2062 (2001)
52. Pilette, C., "CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge", Eur. Respir. J, 23, pp.876~884 (2004)
53. Sekiya, T., "Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine(TARC)in serum and induced sputum of asthmatics", Allergy, 57, pp.173~177 (2002)
54. Meyer, E. H., "Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+T cells", Proc. Natl Acad. Sci. USA, 103, pp.2782~2787 (2006)
55. Sen, Y., "V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement", J. Immunol, 175, pp.4914~4926 (2005)
56. Umetsu, D. T., "Asthma : an epidemic of dysregulated immunity", Nat. Immunol, 3, pp.715~720 (2002)
57. Thanabalasuriar, A., "iNKT cell emigration out of the lung vasculature requires neutrophils and monocyte-derived dendritic cells in inflammation", Cell Rep, 16, pp.3260~3272 (2016)
58. Brigl, M., "Mechanism of CD1drestricted natural killer T cell activation during microbial infection", Nat. Immunol, 4, pp.1230~1237 (2003)
59. Chun, T., "CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells", J. Exp. Med, 197, pp.907~918 (2003)
60. Venkataswamy, M. M., "Lipid and glycolipid antigens of CD1drestricted natural killer T cells", Semin. Immunol, 22, pp.68~78 (2010)
61. Zhang, Y., "alpha-GalCer and iNKT cell-based cancer immunotherapy : realizing the therapeutic potentials", Front. Immunol, 10, pp.1126~ (2019)
62. O’Keeffe, J., "Invariant natural killer T cells and their ligands : focus on multiple sclerosis", Immunology, 145, pp.468~475 (2015)
63. Kinjo, Y., "Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria", Nat. Immunol, 12, pp.966~974 (2011)
64. Fischer, K., "Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells", Proc. Natl Acad. Sci. USA, 101, pp.10685~10690 (2004)
65. Reilly, E. C., "Cytokine dependent and independent iNKT cell activation", Cytokine, 51, pp.227~231 (2010)
66. Gottschalk, C., "The role of invariant natural killer T cells in dendritic cell licensing, cross-priming, and memory CD8(+)T cell generation", Front. Immunol, 6, pp.379~ (2015)
67. Brigl, M., "Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection", J. Exp. Med, 208, pp.1163~1177 (2011)
68. Paget, C., "Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids", Immunity, 27, pp.597~609 (2007)
69. Salio, M., "Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation", Proc. Natl Acad. Sci. USA, 104, pp.20490~20495 (2007)
70. Paget, C., "Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides", J. Immunol, 182, pp.1846~1853 (2009)
71. Kim, J. H., "Direct engagement of TLR4 in invariant NKT cells regulates immune diseases by differential IL-4 and IFN-gamma production in mice", PLoS ONE, 7, pp.e45348~ (2012)
72. Hwang, S. J., "IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils", J. Immunol, 177, pp.5258~5268 (2006)
73. Kim, J. H., "IFN-gamma-producing NKT cells exacerbate sepsis by enhancing C5a generation via IL-10-mediated inhibition of CD55 expression on neutrophils", Eur. J. Immunol, 44, pp.2025~2035 (2014)
74. Opasawatchai, A., "iNKT cells and their potential lipid ligands during viral infection", Front. Immunol, 6, pp.378~ (2015)
75. Victor, J. R., "New insights into asthma inflammation : focus on iNKT, MAIT, and gammadeltaT cells", Clin. Rev. Allergy Immunol, 59, pp.371~381 (2020)
76. Wilson, S. B., "Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity", Nat. Rev. Immunol, 3, pp.211~222 (2003)
77. Iwamura, C., "Role of NKT cells in allergic asthma", Curr. Opin. Immunol, 22, pp.807~813 (2010)
78. Chackerian, A., "Activation of NKT cells protects mice from tuberculosis", Infect. Immun, 70, pp.6302~6309 (2002)
79. Dempsey, L. A., "NKT cells aid antiviral responses", Nat. Immunol, 19, pp.99~ (2018)
80. Tsao, C. C., "Repeated activation of lung invariant NKT cells results in chronic obstructive pulmonary disease-like symptoms", PLoS ONE, 11, pp.e0147710~ (2016)
81. Kim, J. H., "Natural killer T(NKT)cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma", Am. J. Pathol, 167, pp.1231~1241 (2005)
82. Kim, J. H., "CD1d-restricted IFN-gamma-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophageinflammatory protein-1alpha production and activation of macrophages and dendritic cells", J. Immunol, 186, pp.1432~1441 (2011)
83. Akbari, O., "Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity", Nat. Med, 9, pp.582~588 (2003)
84. Wallace, K. L., "NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3chemokines", Blood, 114, pp.667~676 (2009)
85. Nembrini, C., "IL-17-producing T cells in lung immunity and inflammation", J. Allergy Clin. Immunol, 123, pp.986~994 (2009)
86. Paget, C., "Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection : potential role in protection against lung epithelial damages", J. Biol. Chem, 287, pp.8816~8829 (2012)
87. Murray, M. P., "Stimulation of a subset of natural killer T cells by CD103(+)DC is required for GM-CSF and protection from pneumococcal infection", Cell Rep, 38, pp.110209~ (2022)
88. Kok, W. L., "Pivotal advance : invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection", J. Leukoc. Biol, 91, pp.357~368 (2012)
89. Konishi, J., "The characteristics of human NKT cells in lung cancer–CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients", Hum. Immunol, 65, pp.1377~1388 (2004)
90. Snyder-Cappione, J. E., "Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells", J. Infect. Dis, 195, pp.1361~1364 (2007)
91. Pichavant, M., "Oxidative stress-mediated iNKT-cell activation is involved in COPD pathogenesis", Mucosal Immunol, 7, pp.568~578 (2014)
92. MacIver, N. J., "Metabolic regulation of T lymphocytes", Annu. Rev. Immunol, 31, pp.259~283 (2013)
93. van der Windt, G. J., "Metabolic switching and fuel choice during T-cell differentiation and memory development", Immunol. Rev, 249, pp.27~42 (2012)
94. Rangel Rivera, G. O., "Fundamentals of T cell metabolism and strategies to enhance cancer immunotherapy", Front. Immunol, 12, pp.645242~ (2021)
95. Yarosz, E. L., "Metabolism in invariant natural killer T cells : an overview", Immunometabolism, 3, pp.e210010~ (2021)
96. Kumar, A., "Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function", Proc. Natl Acad. Sci. USA, 116, pp.7439~7448 (2019)
97. Pyaram, K., "Keap1-Nrf2 system plays an important role in invariant natural killer T cell development and homeostasis", Cell Rep, 27, pp.699~707 (2019)
98. Weng, X., "Mitochondrial metabolism is essential for invariant natural killer T cell development and function", Proc. Natl Acad. Sci. USA, 118, pp.e2021385118~ (2021)
99. Larkin, J., "CD44 differentially activates mouse NK T cells and conventional T cells", J. Immunol, 177, pp.268~279 (2006)
100. Brossay, L., "CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution", J. Exp. Med, 188, pp.1521~1528 (1998)
101. Meldrum, O. W., "Mucus, microbiomes and pulmonary disease", Biomedicines, 9, pp.675~ (2021)
102. Huffnagle, G. B., "The respiratory tract microbiome and lung inflammation : a two-way street", Mucosal Immunol, 10, pp.299~306 (2017)
103. Fu, S., "Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells", Nat. Commun, 11, pp.438~ (2020)
104. Diseases, G. B. D., "Global burden of 369 diseases and injuries in 204countries and territories, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019", Lancet, 396, pp.1204~1222 (2020)
105. Paget, C., "Role of type 1 natural killer T cells in pulmonary immunity", Mucosal Immunol, 6, pp.1054~1067 (2013)
106. Olin, J. T., "Asthma : pathogenesis and novel drugs for treatment", BMJ, 349, pp.g5517~ (2014)
107. Romanet-Manent, S., "Allergic vs nonallergic asthma : what makes the difference?", Allergy, 57, pp.607~613 (2002)
108. Schatz, M., "The allergic asthma phenotype", J. Allergy Clin. Immunol. Pr, 2, pp.645~648 (2014)
109. Cosmi, L., "Th17 cells : new players in asthma pathogenesis", Allergy, 66, pp.989~998 (2011)
110. Umetsu, D. T., "Natural killer T cells are important in the pathogenesis of asthma : the many pathways to asthma", J. Allergy Clin. Immunol, 125, pp.975~979 (2010)
111. Hachem, P., "Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice : role of IFN-gamma", Eur. J. Immunol, 35, pp.2793~2802 (2005)
112. Lisbonne, M., "Cutting edge : invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model", J. Immunol, 171, pp.1637~1641 (2003)
113. Matangkasombut, P., "Direct activation of natural killer T cells induces airway hyperreactivity in nonhuman primates", J. Allergy Clin. Immunol, 121, pp.1287~1289 (2008)
114. Kim, J. O., "Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model", J. Allergy Clin. Immunol, 114, pp.1332~1338 (2004)
115. Gour, N., "IL-4 and IL-13 signaling in allergic airway disease", Cytokine, 75, pp.68~78 (2015)
116. Hiraishi, Y., "IL-33, IL-25 and TSLP contribute to development of fungalassociated protease-induced innate-type airway inflammation", Sci. Rep, 8, pp.18052~ (2018)
117. Rachitskaya, A. V., "Cutting edge : NKT cells constitutively express IL-23receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion", J. Immunol, 180, pp.5167~5171 (2008)
118. Goto, M., "Murine NKT cells produce Th17 cytokine interleukin-22", Cell Immunol, 254, pp.81~84 (2009)
119. Michel, M. L., "Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia", J. Exp. Med, 204, pp.995~1001 (2007)
120. Terashima, A., "A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity", J. Exp. Med, 205, pp.2727~2733 (2008)
121. Theisen, D., "The role of cDC1s in vivo: CD8 T cell priming through cross-presentation", F1000Res, 6, pp.98~ (2017)
122. Nakano, H., "Pulmonary CD103(+)dendritic cells prime Th2 responses to inhaled allergens", Mucosal Immunol, 5, pp.53~65 (2012)
123. Thomas, S. Y., "Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma", J. Allergy Clin. Immunol, 125, pp.980~984 (2010)
124. Das, J., "Natural killer T cells and CD8+ T cells are dispensable for T celldependent allergic airway inflammation", Nat. Med, 12, pp.1345~1346 (2006)
125. Hyde, E. J., "Similar immune mechanisms control experimental airway eosinophilia elicited by different allergens and treatment protocols", BMC Immunol, 20, pp.18~ (2019)
126. Constantinides, M. G, "Interactions between the microbiota and innate and innate-like lymphocytes", J. Leukoc. Biol, 103, pp.409~419 (2018)
127. Pham-Thi, N., "Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma", J. Allergy Clin. Immunol, 117, pp.217~218 (2006)
128. Fernandes, G. F. S., "Tuberculosis drug discovery : challenges and new horizons", J. Med. Chem, 65, pp.7489~7531 (2022)
129. Koch, A., "Mycobacterium tuberculosis", Trends Microbiol, 26, pp.555~556 (2018)
130. Al-Humadi, H. W., "Addressing the challenges of tuberculosis : a brief historical account", Front. Pharm, 8, pp.689~ (2017)
131. Arora, P., "CD1d and natural killer T cells in immunity to Mycobacterium tuberculosis", Adv. Exp. Med. Biol, 783, pp.199~223 (2013)
132. Sada-Ovalle, I., "Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria", PLoS Pathog, 4, pp.e1000239~ (2008)
133. Rothchild, A. C., "iNKT cell production of GM-CSF controls Mycobacterium tuberculosis", PLoS Pathog, 10, pp.e1003805~ (2014)
134. Zenteno-Cuevas, R., "Update on the development of TB Vaccines", Curr. Pharm. Biotechnol, 14, pp.940~946 (2013)
135. Montoya, C. J., "Invariant NKT cells from HIV-1 or Mycobacterium tuberculosisinfected patients express an activated phenotype", Clin. Immunol, 127, pp.1~6 (2008)
136. Singh, A., "Programmed death-1 receptor suppresses gamma-IFN producing NKT cells in human tuberculosis", Tuberculosis, 94, pp.197~206 (2014)
137. Sutherland, J. S., "High granulocyte", lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting, 2009, pp.89, 398~404
138. Gansert, J. L., "Human NKT cells express granulysin and exhibit antimycobacterial activity", J. Immunol, 170, pp.3154~3161 (2003)
139. Zhao, J., "Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model", Elife, 4, pp.e08525~ (2015)
140. Huang, S., "Targeting innate-like T cells in tuberculosis", Front. Immunol, 7, pp.594~ (2016)
141. Hutchinson, E. C., "Influenza virus", Trends Microbiol, 26, pp.809~810 (2018)
142. Paget, C., "Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2pneumonia", J. Immunol, 186, pp.5590~5602 (2011)
143. De Santo, C., "Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans", J. Clin. Invest, 118, pp.4036~4048 (2008)
144. Driver, J. P., "Modulation of immune responses to influenza A virus vaccines by natural killer T cells", Front. Immunol, 11, pp.2172~ (2020)
145. Bjorkstrom, N. K., "Natural killer cells and unconventional T cells in COVID-19", Curr. Opin. Virol, 49, pp.176~182 (2021)
146. Liu, J., "Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment", mBio, 12, pp.e00085~ (2021)
147. Dong Min Kim, "Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients", The Korean Journal of Internal Medicine, 37(1), pp.201~209 (2022), 대한내과학회[DOI]
148. Li, Y. R., "Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention", Stem Cell Res. Ther, 13, pp.112~ (2022)
149. Mannino, D. M., "Economic burden of COPD in the presence of comorbidities", Chest, 148, pp.138~150 (2015)
150. Mirza, S., "COPD guidelines : a review of the 2018 GOLD report", Mayo Clin. Proc, 93, pp.1488~1502 (2018)
151. Tang, Y., "Increased numbers of NK cells, NKT-like cells, and NK inhibitory receptors in peripheral blood of patients with chronic obstructive pulmonary disease", Clin. Dev. Immunol, 2013, pp.721782~ (2013)
152. Kim, E. Y., "Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease", Nat. Med, 14, pp.633~640 (2008)
153. Noble, P. W., "Pulmonary fibrosis : patterns and perpetrators", J. Clin. Invest, 122, pp.2756~2762 (2012)
154. Kendall, R. T., "Fibroblasts in fibrosis : novel roles and mediators", Front. Pharm, 5, pp.123~ (2014)
155. Yue, X., "TGF-beta: titan of lung fibrogenesis", Curr. Enzym. Inhib, 6 (2010)[DOI]
156. Grabarz, F., "Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis", Inflammopharmacology, 26, pp.491~504 (2018)
157. Ogawa, T., "Macrophages in lung fibrosis", Int. Immunol, 33, pp.665~671 (2021)
158. Costabel, U., "Hypersensitivity pneumonitis", Nat. Rev. Dis. Prim, 6, pp.65~ (2020)
159. Ward, P. A., "New insights into molecular mechanisms of immune complex-induced injury in lung", Front. Immunol, 7, pp.86~ (2016)

관련 논문AI추천